An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study

BACKGROUND: Ending the global tuberculosis (TB) epidemic requires a focus on treating individuals with latent TB infection (LTBI) to prevent future cases. Promising trials of shorter regimens have shown them to be effective as preventative TB treatment, however there is a paucity of data on self-adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Surey, J., Stagg, H. R., Yates, T. A., Lipman, M., White, P. J., Charlett, A., Muñoz, L., Gosce, L., Rangaka, M. X., Francis, M., Hack, V., Kunst, H., Abubakar, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818935/
https://www.ncbi.nlm.nih.gov/pubmed/33478428
http://dx.doi.org/10.1186/s12879-021-05766-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818935/
https://www.ncbi.nlm.nih.gov/pubmed/33478428
http://dx.doi.org/10.1186/s12879-021-05766-9

Ejemplares similares